Bacterial And Viral Specimen Collection Market Size, Share, & Trends Analysis Report By Product (Bacterial Specimen Collection, Viral Specimen Collection), By Application, By End Use, By Region, And Segment Forecasts,
Published Date: May - 2025 | Publisher: MIR | No of Pages: 260 | Industry: healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2999 Download Sample Ask for Discount Request CustomizationMarket Size & Trends
The size of the global bacterial and viral specimen collection market was USD 15.49 billion in 2024 and is anticipated to grow at a CAGR of 14.5% from 2025 to 2035, with the growing incidence of infectious diseases and increased awareness and adoption of preventive healthcare. The need for diagnostic testing to identify infections early is on the rise with escalating global health challenges. This has generated a heightened demand for effective specimen collection equipment and methods. Besides, greater awareness regarding vaccination, hygiene, and disease prevention spurs the market, which induces individuals as well as medical centers to make investments in the correct specimen collection to ensure effective diagnosis and treatment.
The increased usage of molecular diagnostics and diagnostic technologies are set to propel the industry of bacterial and viral specimen collection. Molecular testing techniques, including PCR and next-generation sequencing, allow for rapid and specific identification of pathogens. These technologies have created more demand for high-quality sample collection equipment to maintain sample integrity. Additionally, the constant advancements in diagnostic technologies make it possible for them to detect a wider spectrum of infections, compelling health care providers to make investments in sophisticated sample collection equipment to aid these diagnostic steps.
Report Coverage & Deliverables
- Competitive benchmarking
- Historical data & forecasts
- Company revenue shares
- Regional opportunities
- Latest trends & dynamics
Market Concentration & Characteristics
The market growth stage is medium, and the pace of growth is accelerating. Ongoing efforts by major market participants, including pharmaceutical companies and research organizations, have resulted in concentrated market scenarios. Key players increasingly focus on innovations in specimen collection technologies, strategic acquisitions, and collaborations to expand their product portfolios and enhance market reach. This consolidation allows the companies to leverage economies of scale, streamline distribution channels, and offer comprehensive solutions. The competitive landscape has intensified, with leading players shaping industry standards and pushing for greater efficiency and accuracy in specimen collection processes, thus driving market growth.For instance, BD collaborated with Babson Diagnostics in February 2020 to introduce small-volume blood collection solutions for retail pharmacies. Under the partnership, they combined BD’s blood collection device with Babson’s automated sample handling and analytical technologies to make blood testing more accessible and convenient.
The international market is defined by high levels of innovation as a result of increased use of advanced healthcare technologies. Sophisticated diagnostic equipment, including automated collection devices and molecular testing, is enhancing the precision and speed of specimen testing. These technologies automatize processes, decrease errors caused by human intervention, and increase overall efficiency in diagnostic procedures. Moreover, integration with digital health platforms enables improved tracking and analysis of specimens, which also increases market demand. This transition to more efficient, accurate methods is driving the market's rapid growth and development.
New regulations heavily influence the bacterial and viral specimen collection industry by providing standardization and enhancing safety measures. Strict guidelines for specimen collection, handling, and transport increase the accuracy and reliability of diagnostic outcomes. Regulatory approvals also stimulate innovation by establishing definitive quality standards and prompting manufacturers to create more sophisticated, effective collection devices. In addition, regulatory systems ensure health and safety compliance, building trust in the market. These innovations are stimulating growth in the industry, with healthcare providers giving top priority to regulated, high-quality specimen collection solutions.
Product Insights
The viral specimen collection segment dominated the market with the largest revenue share of 57.3% in 2024 due toincreasing demand for precise and rapid diagnostic solutions. The growing prevalence of viral infections has driven healthcare facilities to prioritize advanced collection methods, ensuring accurate detection and treatment. Technological advancements in specimen transport and preservation have strengthened this segment's dominance. Rising global awareness about infectious diseases and the need for early intervention have encouraged investments in efficient collection systems, solidifying viral specimen collection’s position in the market.
The bacterial specimen collection segment is anticipated to grow at a significant CAGR of 11.0% from 2025 to 2035, driven by rising concerns over antibiotic-resistant infections and emerging bacterial diseases. The surge in healthcare initiatives promoting early bacterial detection has amplified demand for advanced collection methods. Innovations in microbiological testing and enhanced regulatory support are accelerating the adoption of bacterial specimen collection kits. Increased research and disease surveillance funding is propelling the growth of this segment, making it a key field for the expanding diagnostic market.
Application Insights
Diagnostics was the largest market segment in 2024 due tothe growing demand for precise and quick detection of diseases. The spread of infectious diseases has driven the demand for effective diagnostic solutions, affirming the stronghold of the segment. Advances in molecular diagnostics and point-of-care diagnostics have enhanced collection and analysis processes. Increased investments in healthcare facilities and government policies favoring early disease detection have also bolstered its status.
The research segment is likely to witness substantial growth over the forecast period due to the global interest in novel pathogens and antimicrobial resistance. Increasing activities in vaccine development and epidemiological research have raised the demand for quality specimen collection. Improvement in microbiological methods and genomic sequencing facilitates enhanced research potential, which increases the demand for specialty collection kits. Growing government and private sector funding for infectious disease research also drives this segment.
End Use Insights
The hospital & clinics segment dominated the revenue share in 2024 because of their significant position in disease diagnosis and patient care. The immense patient flow of such healthcare facilities has propelled the demand for effective specimen collection techniques, delivering accurate and prompt testing. Investments in cutting-edge diagnostic infrastructure and strict infection control have also fortified this segment's position. Heightened consciousness of the early detection of diseases and a desire for precise laboratory results will continue to propel hospitals and clinics as the ultimate focal points of specimen collection and testing services.
The at-home testing sector is expected to be the largest growing sector over the forecasted period, with driving forces consisting of growing need for convenient solutions for healthcare. Diagnostic technology has been empowered in the sense that people can easily do reliable tests from home to reduce reliance on clinical consultations. Increased understanding of early disease diagnosis and infection prevention has driven the use of self-testing kits at a fast pace. Increased availability of online platforms and telehealth services has provided easy access to home specimen collection, making this segment a leading factor in market growth in the future.
Regional Insights
North America bacterial and viral specimen collection market dominated the global market with the largest revenue share of 45.0% in 2024.The rising prevalence of infectious diseases and the surge in home testing adoption are driving the market. Increasing outbreaks and heightened awareness of early disease detection fuel the demand for efficient collection solutions. Innovations in at-home testing kits provide convenience and accessibility, accelerating widespread adoption. Healthcare providers and diagnostic companies in the region are investing in advanced specimen collection technologies to meet the growing consumer needs. Strong government support and telehealth integration further drive the market, making specimen collection a critical component of public health strategies.
U.S. Bacterial and Viral Specimen Collection Market Trends
TheU.S. bacterial and viral specimen collection market held the highest regional market share in 2024.Growth in point-of-care testing and increased efforts in monitoring antimicrobial resistance drive growth in the U.S. bacterial and viral specimen collection market. Rapid diagnostic solutions are simplifying specimen collection, enabling faster disease detection and treatment. Growing anxiety about antibiotic-resistant infections has accelerated research activity, fueling the demand for advanced specimen handling. Clinicians and laboratories are investing in sophisticated collection technologies to enhance accuracy and efficiency. Government programs aimed at supporting infection control and surveillance are complementing market growth, defining the future of diagnostic specimen collection.
Europe Bacterial and Viral Specimen Collection Market Trends
Europe viral and bacterial specimen collection market is expected to see substantial growth during the forecast period, following advances in diagnostics technology and growing laboratory automation. Advanced molecular testing and AI-based solutions improve accuracy and productivity in specimen handling. Automated processes eliminate human error, simplify workflows, and hasten the detection of disease, enhancing health outcomes. Increased investment in digital and robotics-based diagnostics is revolutionizing specimen collection processes. The need for speedier and more accurate outcomes further reinforces the take-up of novel technologies, maintaining growth within the regional diagnostic sector.
Asia Pacific Bacterial and Viral Specimen Collection Market Trends
Asia Pacific bacterial and viral specimen collection market will be the region expected to grow with the highest CAGR of 16.2% between 2025-2030 owing to growing telemedicine services and rising investment in healthcare infrastructure. Telemedicine consultations and health digital platforms drive the need for sophisticated specimen collection technologies, providing access to remote areas. Diagnostic centers and lab modernization are being funded by governments and private institutions, boosting efficiency and accuracy in disease identification. Improved healthcare networks and growing awareness of early testing further spur the use of innovative specimen collection technologies throughout the region.
India bacterial and viral specimen collection market is anticipated to develop at the highest CAGR over the forecast period.Increasing awareness towards early detection of disease and technical advancements in biopharmaceutical and vaccine research are expected to drive the India bacterial and viral specimen collection market. Increased public health activities and awareness programs promote proactive diagnostics, leading to augmented demand for effective specimen collection procedures. Vaccine production expansion and pharmaceutical breakthroughs fuel research-oriented specimen handling technologies. Funding from the government and private sector further supports laboratory facilities, facilitating efficient collection and analysis. Health policies consolidated further accelerate market growth, positioning specimen collection as a pivotal element in preventing disease.
Key Bacterial And Viral Specimen Collection Company Insights
Some of the prominent companies that operate in the field of bacterial and viral specimen collection are Puritan Medical Products; Copan Diagnostics Inc.; BD (Becton, Dickinson and Company); Thermo Fisher Scientific Inc.; and QuidelOrtho Corporation.
Becton, Dickinson and Company delivers medical technology, devices, and lab equipment that specialize in diagnostic systems, infection prevention, and drug delivery solutions. It serves healthcare providers with innovative solutions to care for their patients and perform medical research.
Thermo Fisher Scientific Inc. provides laboratory instruments, reagents, and consumables for pharmaceuticals, diagnostics, and scientific research. It offers cutting-edge solutions for clinical and life sciences, biotechnology, and applications, facilitating healthcare innovation, environmental analysis, and industrial research.
Key Bacterial And Viral Specimen Collection Companies
The following are the leading companies in the bacterial and viral specimen collection market. These companies collectively hold the largest market share and dictate industry trends.
- Puritan Medical Products
- Copan Diagnostics Inc.
- BD (Becton, Dickinson and Company)
- Thermo Fisher Scientific Inc.
- QuidelOrtho Corporation
- Longhorn Vaccines and Diagnostics, LLC
- Pretium Packaging
- Trinity Biotech
- Medical Wire & Equipment
- HiMedia Laboratories, LLC
- Hardy Diagnostics
- Wuxi NEST Biotechnology Co., Ltd. (Nest Scientific)
- VIRCELL SL
- DiaSorin S.p.A.
- Titan Biotech
Recent Developments
-
In December 2024, BD and Babson Diagnostics expanded fingertip blood collection technology in the U.S., enabling accurate testing from just six drops of blood. Combining BD’s MiniDraw and Babson’s BetterWay allows easier, less-invasive sampling by any trained healthcare worker, even without phlebotomy experience, in various care settings.
-
In April 2024,BD introduced the BD Vacutainer UltraTouch Push Button Blood Collection Set in India. This new device uses BD RightGauge and BD PentaPoint technologies to allow for thinner needles, which reduce insertion pain during blood collection.
Bacterial And Viral Specimen Collection Market Report Scope
|
Report Attribute |
Details |
|
Market size value in 2025 |
USD 16.95 billion |
|
Revenue forecast in 2030 |
USD 33.37 billion |
|
Growth Rate |
CAGR of 14.5% from 2025 to 2035 |
|
Base year for estimation |
2024 |
|
Historical data |
2018 - 2023 |
|
Forecast period |
2025 - 2035 |
|
Report updated |
May 2025 |
|
Quantitative units |
Revenue in USD million and CAGR from 2025 to 2035 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Product, application, end use, and region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
|
Country scope |
U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, Denmark, Sweden, Norway, Japan, China, India, Australia, Thailand, South Korea, Brazil, Argentina, South Africa, Saudi Arabia, UAE, Kuwait |
|
Key companies profiled |
Puritan Medical Products; Copan Diagnostics Inc.; BD (Becton, Dickinson and Company); Thermo Fisher Scientific Inc.; QuidelOrtho Corporation;Longhorn Vaccines and Diagnostics, LLC; Pretium Packaging; Trinity Biotech; Medical Wire & Equipment; HiMedia Laboratories, LLC; Hardy Diagnostics; Wuxi NEST Biotechnology Co., Ltd. (Nest Scientific); VIRCELL SL; DiaSorin S.p.A.; and Titan Biotech |
|
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
|
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
Global Bacterial And Viral Specimen Collection Market Report Segmentation
Product Outlook (Revenue, USD Million, 2018 - 2035)
-
-
Bacterial Specimen Collection
-
Swabs
-
Bacterial Transport Media
-
Blood Collection Kits
-
Other Consumables
-
-
Viral Specimen Collection
-
Swabs
-
Viral Transport Media
-
Blood Collection Kits
-
Other Consumables
-
-
-
Application Outlook (Revenue, USD Million, 2018 - 2035)
-
Diagnostics
-
Research
-
-
End Use Outlook (Revenue, USD Million, 2018 - 2035)
-
Hospitals & Clinics
-
Home Testing
-
Research Laboratories
-
-
Regional Outlook (Revenue, USD Million, 2018 - 2035)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
U.K.
-
Germany
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
Japan
-
China
-
India
-
Australia
-
Thailand
-
South Korea
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East & Africa
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy